Omentin-1 inhibits the development of benign prostatic hyperplasia by attenuating local inflammation

CONCLUSION: The study demonstrates that ITLN-1 plays a significant role in inhibiting the development of BPH by reducing local inflammation in the prostate gland. These findings highlight the potential of ITLN-1 as a therapeutic target in the management of BPH.PMID:38519941 | PMC:PMC10960431 | DOI:10.1186/s10020-024-00805-y

Source: Molecular Medicine - March 23, 2024 Category: Molecular Biology Authors: Yi-Yi Wang Guo-Qiang Zhu Kun Xia Hong-Bo Zeng Yun-Hui He Hui Xie Zhen-Xing Wang Ran Xu Source Type: research